The proportion of critical patients within the group of patients that did not express CHRFAM7A was higher than in those that expressed CHRFAM7A (50% versus 38.1%) but the difference did not reach statistical significance.
← all excerpts
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
1
—
—